Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
about
Clinical validity and utility of genetic risk scores in prostate cancerA comparison of genetic risk score with family history for estimating prostate cancer riskPersonalized prostate cancer care: from screening to treatment.Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.Exome-based genome-wide association study and risk assessment using genetic risk score to prostate cancer in the Korean population.Genetic predisposition to prostate cancer.A review of prostate cancer genome wide association studies (GWAS).
P2860
Q26746219-ECB53680-9783-4609-B5EE-E090CC20946AQ26752649-6808DE57-3653-4C9D-99D3-867EE2B9AF66Q37113160-9136ECB0-B879-4331-8BDF-2F166E7ADC13Q37113165-9433FC79-A0E5-4316-A57A-D73EFC1F9F88Q38734618-8B5DD33A-EF79-4DC5-BCD8-BD0652D7F781Q39035687-56552D87-687D-4E58-ADD1-CC43A9C85DDAQ48515655-315E2779-0FF6-4E2F-9D25-4060EDF260DE
P2860
Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prostate genetic score (PGS-33 ...... tate cancer in the PLCO trial.
@en
type
label
Prostate genetic score (PGS-33 ...... tate cancer in the PLCO trial.
@en
prefLabel
Prostate genetic score (PGS-33 ...... tate cancer in the PLCO trial.
@en
P2093
P2860
P356
P1433
P1476
Prostate genetic score (PGS-33 ...... tate cancer in the PLCO trial.
@en
P2093
A Karim Kader
Haitao Chen
Michael A Liss
P2860
P304
P356
10.1002/PROS.23012
P50
P577
2015-05-15T00:00:00Z